TWST

#1255
Twist Bioscience Corporation - Common Stock
66.8 7 USD
-3.13%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
66.87
66.87
Jahresspanne
23.30
69.20
Tagesänderung
-3.13%
Monatliche Änderung
+16.30%
6 month change
+114.05%
Jahresänderung
+133.73%
Vorheriger Schlusskurs
69.0 3
Open
66.8 7
Tief
66.8 7
High
66.8 7
Volumen
165
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
  • Market Capitalization 4.16 B
  • Employee 979
  • Founded 2013
  • CEO Emily LeProust
  • Website www.twistbioscience.com
  • Headquarter Delaware, United States
  • FIGI BBG006KDCHJ4
  • Industry Diagnostik und Untersuchungen
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
-21.65
Preis-Umsatz-Verhältnis
4.47

Twist Bioscience Corporation - Common Stock

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

Nachrichten